CANCER 2009 (Draft Programme)
7th INTERNATIONAL CANCER CONFERENCE
VENUE
INSTITUTE OF MOLECULAR MEDICINE,
ST JAMES'S HOSPITAL AND TCD
13th – 15th May 2009
WEDNESDAY 13TH MAY 2009
St James’s Hospital - Belfast City Hospital – National Cancer Institute Forum
EMBEDDING TRANSLATIONAL MEDICINE IN CANCER CARE
9.30 Registration for CANCER 2009
9.40 Welcome and Opening of Forum
SESSION I: “INTEGRATING BIOLOGY, PATHOLOGY AND CANCER RISK”
Chairpersons: Prof Ken O Byrne, St James’s Hospital and Trinity College Dublin, Ireland;
Prof Conor O Keane, Mater Misercordiae University Hospital and University College Dublin, Ireland
9.45 Introduction
Prof Ken O Byrne, St James’s Hospital and Trinity College Dublin, Ireland
9.50 “MicroRNAs – potential biomarkers in cancer or red herrings?”
Prof Orla Sheils, St James’s Hospital and Trinity College Dublin, Ireland
10.15 “Stem cells in the prevention of Barrett's metaplasia; the root of cancer”
Prof Janusz Jankowski, Department of Clinical Pharmacology, University of Oxford, UK
10.45 “There may be trouble ahead” – Assessing genetic risk of lung cancer”
Prof Tim Eisen, Cambridge Cancer Centre, University of Cambridge, Cambridge, UK
11.15 Round Table Discussion
Moderator:
11.25 COFFEE AND EXHIBITION/ POSTER VIEWING
Sponsored by an education grant by 
SYMPOSIUM I: NEW FRONTIERS IN COLORECTAL CANCER
Chairpersons: Prof Elaine Kay, Beaumont Hospital and Royal College of Surgeons in Ireland, Dublin, Ireland; Dr John Kennedy, St James’s Hospita,l Dublin, Ireland
11.55 Introduction
Prof Elaine Kay, Beaumont Hospital and Royal College of Surgeons in Ireland, Dublin, Ireland
12.00 “Tailoring treatment to your patients; molecular medicine takes centre stage”
Professor Sabine Tejpar, University Hospital Gasthuisberg, University of Leuven, Belgium
12.30 Tailoring surgery to your patients: minimally or maximally invasive?
Prof Ronan O Connell, St Vincents University Hospital and University College Dublin, Dublin, Ireland
12.55 Round Table Discussion
Moderator: Dr John Kennedy St James’s Hospital, Dublin, Ireland
13.05 End of Symposium
13.05 LUNCH AND EXHIBITION/ POSTER VIEWING
SESSION II: “CANCER THERAPEUTICS IN THE 21ST CENTURY” 
Chairpersons: Dr Robert O Connor, Chairperson, Translational Disease Specific Subgroup, All Ireland Cooperative Oncology Research Group; 2nd Chairperson to be confirmed
13.50 Introduction
Dr Dean Fennell, Centre for Cancer Research and Cell Biology, Queens University Belfast, Northern Ireland
13.55 “FKBPL: a novel anti-angiogenic protein that targets CD44”
Dr Tracey Robson, School of Pharmacy, Queens University Belfast, Northern Ireland
14.20 Casein kinase, a bifunctional regulator of NF-kB and lymphoma cell survival; is this a new potential target for cancer therapeutics?
Dr Mike Lenardo, Chief, Molecular Development of the Immune System Section, National Institutes of Health, Washington, USA
14.50 “Epigenetic targeting and its role in cancer therapy”
Prof Robert Browne, Professor of Translational Oncology, Imperial College London, UK
15.20 "Translational Research - the appliance of science!"
Prof Herbie Newell, Professor of Cancer Therapeutics, Northern Institute of Cancer Research, University of Newcastle, UK
15.45 Round Table Discussion
Moderator: Prof Cormac Taylor, University College Dublin, Ireland
15.55 COFFEE AND EXHIBITION/ POSTER VIEWING
16.15 THE NATIONAL CANCER INSTITUTE LECTURE
Introduced by Dr Jim Meaney, Director, Centre for Advanced Medical Imaging
“Oncologic Imaging, Endless Horizons !”
Prof Hedvig Hricak, Chair, Department of Radiology, Memorial Sloan-Kettering Cancer Centre, New York, USA
16.50 End of Forum
SESSION III: PUBLIC SYMPOSIUM - To register for the Public Symposium. Please email fhoolahan@stjames.ie indicating the names of those you want to register.
THE FIGHT AGAINST CANCER; WHERE DO WE STAND?
Help us to help you find out more about cancer?
Can you reduce your risk of getting this disease?
Chairpersons: Dr John Bowman, Broadcaster and Author, Dr Muiris Houston, Irish Times
16.30 Registration (Limited places)
17.00 Launch of Symposium
Speaker to be confirmed
17.10 Understanding cancer; is it all in your genes?
Prof Mark Lawler, St James’s Hospital and Trinity College Dublin, Ireland
17.35 Man, Woman, Child; perspectives on cancer risk and cancer care
Prof Ralph DeVere White Prof John Crown Dr Joe Simone
UC Davis Cancer Centre St Vincent’s University University of Florida-Shands
California, USA Hospital, Dublin Cancer Center, Florida, USA
18.55 How can we stop ourselves from getting cancer?
Dr Fenton Howell, Health Service Executive, Ireland
19.20 The Future of Cancer Medicine
Prof Patrick Johnston, Queens University Belfast, Northern Ireland
19.50 Questions and Answers
Additional Panellists: Dr Tony O'Brien, National Cancer Screening Service Board, Mr Thomas Lynch, St James’s Hospital, Ms Kathleen O'Meara, Irish Cancer Society, Prof Owen Smith Our Lady’s Childrens Hospital, Crumlin
20.15 Refreshments
THURSDAY 14TH MAY
08.30am REGISTRATION FOR CANCER 2009
SESSION IV: CANCER STRATEGY: HOW, HOW FAR, HOW MUCH?
Chairpersons: Prof John Reynolds, St James’s Hospital and Trinity College Dublin, Ireland
Dr Davida De La Harpe, Health Services Executive, Ireland
8.50 Introduction
Prof John Reynolds, St James’s Hospital and Trinity College Dublin, Ireland
8.55 “Cancer Control, the challenge for Healthcare Systems”
Ms Mary Jackson, Cancer Policy Unit, Department of Health and Children, Ireland
9.15 “Cancer Clinical Trials in Ireland; moving forward”.
Dr Paul Browne, Chairperson, All Ireland Co-operative Oncology Research Group
9.30 OPENING ADDRESS
Mr Ian Carter, CEO, St James’s Hospital, Dublin, Ireland
Prof Tom Keane, Interim Director, National Cancer Control Programme, Ireland.
Ms Mary Harney, TD, Minister for Health and Children.
Prof Dermot Kelleher, Head of School of Medicine and Vice Dean for Medical Affairs, Trinity College Dublin, Ireland.
10.10 “The Many Faces of Quality Cancer Care”
Dr Joe Simone, Director, University of Florida-Shands Cancer Center, Florida, USA
10.45 “Team Science; The Core of a Functioning Cancer Program”
Prof Ralph DeVere White, Director, UC Davis Cancer Centre, California, USA
11.20 Round Table Discussion
Moderator: Prof Luke Clancy, Director, TobaccoFree Research Institute, Dublin, Ireland
11.30 COFFEE AND EXHIBITION/ POSTER VIEWING
12.00 KEYNOTE ADDRESS: The Health Research Board Lecture 
Introduced By Mr Enda Connolly, CEO Health Research Board, Dublin, Ireland
“The cost of cancer and access to innovative drugs in oncology”
Prof David Khayat, Head, Department of Medical Oncology, Salpetriere Hospital; Honorary President, French National Cancer Institute, Paris, France
12.40 LUNCH AND EXHIBITION/ POSTER VIEWING
Prof Tom Keane, Interim Director, National Cancer Control Programme, Ireland
Ms Mary Harney, TD, Minister for Health and Children, Ireland
Other speakers to be confirmed
SESSION V: CANCER: WHO’S AT RISK?
Chairpersons: Dr Anna Gavin, Director, Northern Ireland Cancer Registry, Belfast, Northern Ireland; Prof Shane Allwright, Department of Public Health and Primary Care,
Trinity College Dublin, Ireland
13.40 Introduction
Dr Anna Gavin, Director, Northern Ireland Cancer Registry, Belfast, Northern Ireland
13.45 “The causes and prevention of breast cancer”
Prof Valerie Beral, Professor of Cancer Epidemiology, University of Oxford, Oxford, UK
14.15 “Work and cancer - the case of the lymphomas ”
Prof Anthony Staines, Professor of Health Systems Research, Dublin City University, Ireland
14.40 “Obesity and Cancer, prevention lessons learned from tobacco!”
Prof Jane Wardle, Health Behaviour Unit, University College London, UK
SESSION VI: CANCERSTRATEGIC DEVELOPMENT AWARD 
Chairperson: Prof Mark Lawler, St James’s Hospital and Trinity College Dublin, Ireland
15.20 Cancer Strategic Development Award Lecture
“Cancer Developments in the last 2 decades; how have we done?”
Prof Des Carney, Mater Misercordiae University Hospital and University College Dublin, Ireland
16.00 COFFEE AND EXHIBITION/ POSTER VIEWING
SESSION VII: IMPROVING THE PATIENT’S EXPERIENCE
Chairpersons: Ms Barbara Cosgrave, ARC Cancer Support Group, Dublin, Ireland; Ms Mairead Lyons Head of Services, Irish Cancer Society, Ireland
16.30 Introduction
Ms Barbara Cosgrave, ARC Cancer Support Group, Dublin, Ireland
16.35 “Managing Cancer-Related-Fatigue: A home-based programme using cognitive behavioural techniques.”
Dr Sonya Collier, Psychological Medicine Service, St James’s Hospital, Dublin, Ireland
16.50 “The Allotment Project': An Innovative Psychological Service model for Men with Cancer.”
Dr Paul D'Alton, Psycho-Oncology Service, St Vincent's University Hospital, Dublin, Ireland
17.05 Special Lecture
“Cure is not Enough; Long Term Follow-up for Childhood Cancer Survivors.”
Prof Aziza Shad, Lombardi Comprehensive Cancer Centre, University of Georgetown, Washington DC, USA
SESSION VIII: EUROLIFE DISTINGUISHED FACULTY LECTURE
Chairperson: Prof Dermot Kelleher, Head of School of Medicine and Vice Dean for Medical Affairs, Trinity College Dublin, Ireland
17.45 Introduction
Prof Frank Gannon, Director General, Science Foundation Ireland
17.50 “How I moved malignant diseases in the nuclear receptor field”
Prof Pierre Chambon, Institute of Genetics and Molecular and Cellular Biology, University of Strasbourg, France
18.40 End of Day 2
19.30 Reception, The Crypt, Christchurch Cathedral
FRIDAY 15TH MAY 2009
08.30am REGISTRATION AND EXHIBITION/POSTER VIEWING
SESSION IX; SPECIAL SYMPOSIUM: EMPHASISING THE IMPORTANCE OF NURSING IN CANCER CARE (Concurrent session)
Chairpersons: Ms Joan Kelly Nursing Services Manager, Irish Cancer Society, Ireland;
Mr Paul Gallagher, Director of Nursing, St James’s Hospital, Dublin, Ireland
8.45 Introduction
Ms Margaret Codd, Directorate Nurse Manager, St James’s Hospital Dublin, Ireland
8.50 “Delivering advanced oncology nursing practice”
Dr Janice Richmond, Advanced Practitioner Cancer, Letterkenny General Hospital, Donegal, Ireland
9.15 “Breast cancer review clinics; benefits and realities”
Dr Eilis McCaughan, Reader in Cancer Care, Institute of Nursing Research, University of Ulster, Coleraine, Northern Ireland
9.40“Integration of Clinical Pharmacy and an Oncology-Haematology Day Care Unit.”
Ms Fionnuala King, Chief II Pharmacist, St James’s Hospital, Dublin, Ireland
9.55“The impact of the late effects clinic on survivorship post allogenetic stem cell transplantation.”
Ms Mairead Ni Chonghaile, Bone Marrow Transplant Co-ordinator, St James’s Hospital, Dublin, Ireland
10.10 “The Power of Art Therapy in Pediatric Hematology-Oncology ”
Ms Tracy Councill, Lombardi Comprehensive Cancer Centre, University of Georgetown, Washington DC, USA
10.35 Round Table Discussion (Moderator to be confirmed)
10.45 End of Session
SESSION X: CANCER CHEMICAL BIOLOGY; PROVIDING THE IMPETUS FOR CANCER DRUG DEVELOPMENT (Concurrent session)
Chairpersons: Dr David Lloyd, Trinity College Dublin, Ireland; Prof Corrado Santocanale, National University of Ireland, Galway, Ireland
8.55 Introduction
Dr David Lloyd, Dean of Research, Trinity College Dublin, Ireland
9.00 “Cancer Drug development; the industry perspective!”
Dr Damian O Connell, Executive Director, Pfizer Clinical R + D Sandwich, UK and Chairperson, Molecular Medicine Ireland Board
9.30 SPECIAL LECTURE
“Can we really design drugs?”
Prof Rod Hubbard, University of York, UK
10.10 "Improving and extending therapeutic benefit through formulation development”
Dr John Fox, Merrion Pharmaceuticals, Dublin, Ireland
10.20 Round Table Discussion
Moderator: Prof Corrado Santocanale, National University of Ireland, Galway, Ireland
10.25 COFFEE AND EXHIBITION/ POSTER VIEWING
SESSION XI: FRONTIERS IN RADIATION ONCOLOGY
Chairpersons: Prof Donal Hollywood, St Lukes Hospital, St James’s Hospital and Trinity College Dublin, Ireland; Prof Frank Sullivan, University College Hospital, Galway Ireland
10.55 Introduction
Prof Donal Hollywood, St Lukes Hospital, St James’s Hospital and Trinity College Dublin, Ireland 2nd Chairperson to be confirmed
11.00 “Functional molecular prediction and targeting of radiotherapy response”
Prof Anne Hansen Ree, Professor of Oncology, Norwegian Radium Hospital, University of Oslo, Oslo, Norway
STATE OF THE ART LECTURE
11.35 “Intergrating biology and high technology in modern radiation oncology”
Prof Michael Baumann, Professor of Radiation Oncology, University of Dresden, Germany and President European Cancer Organisation
12.15 LUNCH AND EXHIBITION/ POSTER VIEWING
SYMPOSIUM II: DISSECTING THE BIOLOGY OF CANCER
Chairpersons: Prof Rosemary O Connor, Department of Biochemistry, University College Cork, Ireland; Dr Adrian Bracken, Smurfit Institute of Genetics, Trinity College Dublin and Adelaide and Meath incorporating the National Children’s Hospital, Tallaght, Dublin, Ireland.
12.15 Introduction
Prof Rosemary O Connor, Department of Biochemistry, University College Cork, Ireland
12.20State of the Science Lecture
“Pro-Tumor Immunity and breast cancer development”
Prof Lisa Coussens University of California, San Francisco, USA
13.00 End of Symposium
13.00 LUNCH AND EXHIBITION/ POSTER VIEWING
13.45 KEYNOTE LECTURE
Introduced by Sheila O Malley, Chief Nursing Officer Department of Health and Children, Ireland
“The role of the cancer nurse in research and clinical care”
Prof Jessica Corner, Head of the School of Health Sciences, University of Southampton, UK
14.20 SESSION XII: IRISH CANCER SOCIETY LECTURE 
Introduced by Mr John Mc Cormack, CEO, Irish Cancer Society
“Clinical Research Networks; empowering better care for cancer patients”
Prof Peter Selby, Professor of Cancer Medicine, University of Leeds, UK
14.50 Concluding Remarks and End of Meeting
